PRISMADYS: Effect of the Visual Information Change in Functional Dystonia

Sponsor
Fondation Ophtalmologique Adolphe de Rothschild (Other)
Overall Status
Recruiting
CT.gov ID
NCT03270189
Collaborator
(none)
48
1
2
99.4
0.5

Study Details

Study Description

Brief Summary

Cervical dystonia occurring only during the writing task is a rare form for which there is no established treatment. Many authors agree that alteration of sensory integration is associated with dystonia. Similar disturbances in the integration of oculomotor information could have a role in cervical dystonia forms involving visuo-cervico-manual coordination such as handwriting. We hypothesize that orthoptic treatment by wearing prisms when writing (i) will reduce the abnormal posture of the head occurring whilst writing and remove the associated nuchal pain; (ii) the correction after a period of systematic wearing of the prisms during handwriting tasks will have a sustainable effect allowing to keep a normal head position after the suppression of the prisms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of the Visual Information Change in Functional Dystonia
Actual Study Start Date :
Sep 18, 2017
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Jan 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: orthoptic treatment

Patients with cervical dystonia occuring only during handwriting.

Device: prism glasses
orthoptic treatment by wearing prisms when writing

No Intervention: Controls

Patients without cervical dystonia.

Outcome Measures

Primary Outcome Measures

  1. measure of head movement occurring when writing [3 months]

    Difference of the angle measured with and without corrective prisms during the handwriting tasks

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 71 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Case

  • Presenting a cervical dystonia that occurs only during handwriting tasks, diagnosed by a neurologist specialised in movement disorders

  • Being treated or not by injection of Botulinum Neurotoxin (but last injection > 3 months before the initial assessment)

Control

  • No cervical dystonia

  • Same sex, age (± 5 years), socio-professional level and hand laterality as the cases

Exclusion Criteria:

Case

  • Cervical dystonia occuring in other circumstances than handwriting

  • Neurological disease other than cervical dystonia (e.g. Parkinson's syndrome)

  • Pain, trauma or pathology of the cervical spine of another cause than cervical dystonia and which have required medical or surgical treatment in the last 6 months preceding the initial assessment

Control

  • Cervical disorders requiring medical or surgical treatment in the last 6 months prior to the tests

  • Neurological disease affecting the cervical region or the writing hand

  • Uncorrected visual disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondation Ophtalmique Adolphe de Rothschild Paris France 75019

Sponsors and Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

Investigators

  • Study Chair: Jean-Pierre Bleton, PhD, Fondation Ophtalmologique Adolphe de Rothschild

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier:
NCT03270189
Other Study ID Numbers:
  • SSA_2016_23
First Posted:
Sep 1, 2017
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2022